Skip to content

Study for the clinical effectiveness of integrated traditional Chinese and western medicine in prevention and treatment of urinary calculi

Study for the clinical effectiveness of integrated traditional Chinese and western medicine in prevention and treatment of urinary calculi

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR1900028076
Enrollment
Unknown
Registered
2019-12-10
Start date
2019-12-10
Completion date
Unknown
Last updated
2019-12-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

urolithiasis

Interventions

Sponsors

Yueyang Hospital of Integrated Traditional Chinese and Western medicine, Shanghai University of Traditional Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 75 Years

Inclusion criteria

Inclusion criteria: 1. Aged 18 to 74 years old; 2. Meet the conventional standard of diagnosis of urinary tract stones; 3. Meet the TCM syndrome standard of diagnosis of lower coke dampness and heat syndrome; 4. the connection between kidney and ureter, or the ureter at the distal end of calculi without deformity, stenosis, obstruction and postoperative adhesion; 5. the renal function of the affected side was good, and the degree of hydronephrosis was below moderate; 6. the general condition of the whole body is good, with no abnormal liver and kidney functions in the past, and the body can take care of itself; 7. understand and agree to participate in the study and sign the informed consent.

Exclusion criteria

Exclusion criteria: 1. urinary tract infection complicated with systemic symptoms, and the temperature was higher than 38? to diagnose pyelonephritis; 2. complicated urinary tract infection, which occurs due to anatomical deformations of the urinary tract, urinary obstruction such as stones, indwailing catheters, diabetes, immune function impairment and other reasons; 3. complicated with cardiovascular, liver, kidney, hematopoietic system and other serious primary diseases; 4. those who have participated in or are participating in other clinical trials 3 months ago; 5. the researcher considers it inappropriate to participate in the study.

Design outcomes

Primary

MeasureTime frame
Rate of rows of stone;

Countries

China

Contacts

Public ContactYu Peng

Yueyang Hospital of Integrated Traditional Chinese and Western medicine.Shanghai University of Traditional Chinese Medicine

drypeng@sina.com+86 020 65161782- 2117

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026